a month ago
NKTR
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 3%
#131 out of 5216 analysts
Average Return
+35.31%
Win Rate
60%63 out of 105
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Climb Bio IncCLYM | +272.31% | $1.95 | $7.26 | 2025-10-15 - 2026-03-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +262.63% | $8.91 | $32.31 | 2023-03-09 - 2024-03-08 | Strong Buy |
Climb Bio IncCLYM | +261.19% | $2.01 | $7.26 | 2025-09-29 - 2026-03-12 | Strong Buy |
Maze Therapeutics IncMAZE | +238.35% | $15.32 | $51.84 | 2025-09-01 - 2026-03-12 | Strong Buy |
Prometheus Biosciences IncRXDX | +233.20% | $60.00 | $199.92 | 2022-10-02 - 2023-06-15 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
2 months ago
ARDX
2 months ago
ABVX
2 months ago
APGE
2 months ago
APGE
4 months ago
TBPH
4 months ago
CGEM
4 months ago
RNAC
4 months ago
ORKA
5 months ago
ABVX
5 months ago
CLYM
6 months ago
MAZE
8 months ago
TBPH
a year ago
OTLK
a year ago
VRDN
2 years ago
VRDN
2 years ago
PTGX
2 years ago
SYRE
3 years ago
CBAY
3 years ago
CBAY
3 years ago
CBAY
3 years ago
KROS
3 years ago
RXDX
3 years ago
RXDX
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | 5 | Strong Buy | $46.00 | -11.26% | Reiterates | 4 days ago |
Liquidia CorpLQDA | 7 | Strong Buy | $50.00 | +33.05% | Maintains | 8 days ago |
Theravance Biopharma IncTBPH | 5 | Strong Buy | $21.00 | +51.19% | Maintains | 10 days ago |
Innoviva IncINVA | 2 | Strong Buy | $35.00 | +59.31% | Reiterates | 15 days ago |
Akebia Therapeutics IncAKBA | 4 | Strong Buy | $4.00 | +185.71% | Maintains | 16 days ago |
Abivax SaABVX | 5 | Strong Buy | $150.00 | +28.23% | Reiterates | 16 days ago |
Moonlake ImmunotherapeuticsMLTX | 5 | Strong Buy | $30.00 | +76.16% | Maintains | 18 days ago |
Spyre Therapeutics IncSYRE | 5 | Strong Buy | $70.00 | +73.22% | Reiterates | 21 days ago |
Ardelyx IncARDX | 3 | Strong Buy | $17.00 | +200.35% | Reiterates | 21 days ago |
Nektar TherapeuticsNKTR | 4 | Strong Buy | $151.00 | +114.61% | Maintains | a month ago |
Mereo Biopharma Group PLCMREO | 3 | Strong Buy | $1.00 | +158.40% | Reiterates | 2 months ago |
Oruka Therapeutics IncORKA | 4 | Strong Buy | $73.00 | +128.20% | Maintains | 2 months ago |
Rezolute IncRZLT | 5 | Strong Buy | $5.00 | +65.56% | Reiterates | 2 months ago |
Apogee Therapeutics IncAPGE | 4 | Strong Buy | $137.00 | +86.37% | Maintains | 2 months ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $38.00 | +172.40% | Maintains | 4 months ago |
Cartesian Therapeutics IncRNAC | 2 | Strong Buy | $44.00 | +441.87% | Maintains | 4 months ago |
Connect Biopharma Holdings LtdCNTB | 2 | Strong Buy | $10.00 | +257.14% | Reiterates | 4 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +114.71% | Reiterates | 4 months ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -14.06% | Reiterates | 4 months ago |
Climb Bio IncCLYM | 3 | Strong Buy | $8.00 | +10.19% | Reiterates | 5 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $15.00 | +308.16% | Maintains | 5 months ago |
Jade Biosciences IncJBIO | 4 | Strong Buy | $28.00 | +102.02% | Initiates Coverage On | 5 months ago |
Avalo Therapeutics IncAVTX | 2 | Strong Buy | $40.00 | +139.38% | Reiterates | 5 months ago |
Outlook Therapeutics IncOTLK | 4 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Anaptysbio IncANAB | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 2 years ago |
Cymabay Therapeutics IncCBAY | 7 | Strong Buy | $24.00 | N/A | Maintains | 3 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 3 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.